Literature DB >> 7944945

Glycoprotein E of pseudorabies virus and homologous proteins in other alphaherpesvirinae.

L Jacobs1.   

Abstract

This paper reviews biological properties of glycoprotein E (gE) of pseudorabies virus (Aujeszky's disease virus) and homologous proteins in other alphaherpesvirinae. It focuses on the gene encoding gE, conserved regions in the gE protein and its homologs, the complex of gE and gI, biological functions of gE in vitro and in vivo, the role of gE in latency and the role of gE in the induction of humoral and cellular immune responses. Special emphasis is placed on the use of gE as a marker protein in the control and eradication of pseudorabies virus.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7944945     DOI: 10.1007/bf01309470

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  132 in total

1.  Spread of herpes simplex virus (HSV) strains SC16, ANG, ANGpath and its glyC minus and GlyE minus mutants in DBA-2 mice.

Authors:  J Rajcáni; U Herget; H C Kaerner
Journal:  Acta Virol       Date:  1990-08       Impact factor: 1.162

2.  Spread of Aujeszky's disease virus within pig herds in an intensively vaccinated region.

Authors:  J A Stegeman; T G Kimman; J T Van Oirschot; M J Tielen; W A Hunneman
Journal:  Vet Rec       Date:  1994-03-26       Impact factor: 2.695

3.  Cells expressing herpes simplex virus glycoprotein gC but not gB, gD, or gE are recognized by murine virus-specific cytotoxic T lymphocytes.

Authors:  K L Rosenthal; J R Smiley; S South; D C Johnson
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

4.  A novel function of the herpes simplex virus type 1 Fc receptor: participation in bipolar bridging of antiviral immunoglobulin G.

Authors:  I Frank; H M Friedman
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

5.  Characterization and mapping of simian varicella virus transcripts.

Authors:  W L Gray; N Gusick; T M Fletcher; C Y Pumphrey
Journal:  J Gen Virol       Date:  1993-08       Impact factor: 3.891

6.  The DNA sequence of the equine herpesvirus 4 gene encoding glycoprotein gp17/18, the homologue of herpes simplex virus glycoprotein gD.

Authors:  A A Cullinane; J Neilan; L Wilson; A J Davison; G Allen
Journal:  J Gen Virol       Date:  1993-09       Impact factor: 3.891

7.  DNA sequence and genetic organization of the unique short (US) region of the simian varicella virus genome.

Authors:  T M Fletcher; W L Gray
Journal:  Virology       Date:  1993-04       Impact factor: 3.616

8.  Development of an ELISA for detection of antibodies to glycoprotein I of Aujeszky's disease virus: a method for the serological differentiation between infected and vaccinated pigs.

Authors:  J T van Oirschot; D J Houwers; H J Rziha; P J Moonen
Journal:  J Virol Methods       Date:  1988-12       Impact factor: 2.014

9.  Characterization of dexamethasone-induced reactivation of latent bovine herpesvirus 1.

Authors:  D Rock; J Lokensgard; T Lewis; G Kutish
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

10.  Structural, functional, and immunological characterization of bovine herpesvirus-1 glycoprotein gl expressed by recombinant baculovirus.

Authors:  S van Drunen Littel-van den Hurk; M D Parker; D R Fitzpatrick; J V van den Hurk; M Campos; L A Babiuk; T Zamb
Journal:  Virology       Date:  1992-09       Impact factor: 3.616

View more
  28 in total

1.  Role of the pseudorabies virus gI cytoplasmic domain in neuroinvasion, virulence, and posttranslational N-linked glycosylation.

Authors:  R S Tirabassi; L W Enquist
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  An N-terminal domain of herpes simplex virus type Ig E is capable of forming stable complexes with gI.

Authors:  S M Rizvi; M Raghavan
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

3.  The gE and gI homologs from two alphaherpesviruses have conserved and divergent neuroinvasive properties.

Authors:  A C Knapp; P J Husak; L W Enquist
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

4.  Transcriptome signature of virulent and attenuated pseudorabies virus-infected rodent brain.

Authors:  Christina Paulus; Patricia J Sollars; Gary E Pickard; Lynn W Enquist
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

5.  Translocation and colocalization of ICP4 and ICP0 in cells infected with herpes simplex virus 1 mutants lacking glycoprotein E, glycoprotein I, or the virion host shutoff product of the UL41 gene.

Authors:  Maria Kalamvoki; Jianguo Qu; Bernard Roizman
Journal:  J Virol       Date:  2007-12-05       Impact factor: 5.103

6.  Efficient axonal localization of alphaherpesvirus structural proteins in cultured sympathetic neurons requires viral glycoprotein E.

Authors:  T H Ch'ng; L W Enquist
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

7.  Role of pseudorabies virus Us9, a type II membrane protein, in infection of tissue culture cells and the rat nervous system.

Authors:  A D Brideau; J P Card; L W Enquist
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

8.  Glycoprotein D-negative pseudorabies virus can spread transneuronally via direct neuron-to-neuron transmission in its natural host, the pig, but not after additional inactivation of gE or gI.

Authors:  W Mulder; J Pol; T Kimman; G Kok; J Priem; B Peeters
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

9.  Intracellular traffic of herpes simplex virus glycoprotein gE: characterization of the sorting signals required for its trans-Golgi network localization.

Authors:  A Alconada; U Bauer; B Sodeik; B Hoflack
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

10.  Physical interaction between envelope glycoproteins E and M of pseudorabies virus and the major tegument protein UL49.

Authors:  Walter Fuchs; Barbara G Klupp; Harald Granzow; Christoph Hengartner; Alexandra Brack; Alice Mundt; Lynn W Enquist; Thomas C Mettenleiter
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.